Essential Reads: Transcranial Magnetic Stimulation for Perinatal Depression
TMS in pregnancy and the postpartum period appears to be a promising treatment option with no reports of adverse obstetric outcomes or congenital malformations.
Essential Reads: SSRI Antidepressants During Pregnancy and Risk of Hypertension, Preeclampsia
There is evidence that depression itself can increase risk for hypertension and preeclampsia. Future studies will help to clarify the complex interaction between depression, SSRI treatment and pre-eclampsia.
Essential Reads: Cannabis and Breastfeeding
At this point, the medical use of cannabis is legal in 37 states and the District of Columbia (D.C.). The recreational use of cannabis has been legalized in 21 states and D.C. The downstream effect [...]
National Eating Disorder Awareness Week: Focus on Pregnant and Postpartum Women
Eating disorders are common among women during the childbearing years; however, information on eating disorders in pregnant and postpartum women is relatively sparse.
Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes
The largest study to date observes no increase in risk of autism or ADHD in children with prenatal exposure to benzodiazepines.
Essential Reads: Peer Support Interventions for Perinatal Depression
Peer support interventions can reduce the incidence of postpartum depression and the severity of depressive symptoms.
Essential Reads: Why Non-Randomized Studies Fall Short When Assessing Reproductive Safety
All of our information on the reproductive safety of medications comes from non-randomized studies. However, many of these studies fail to take into consideration other factors associated with maternal psychiatric illness which may also affect outcomes.
Essential Reads: What You Need to Know About Bioidentical Hormone Therapy for Menopausal Symptoms
While many peri- and post-menopausal women request bioidentical hormones, there is no data to suggest that bioidential hormones are safer or more effective than FDA-approved hormone replacement therapies.
Should Valproic Acid Be Used in Women of Reproductive Age? Experts Disagree
The use of valproic acid during pregnancy is associated with a significant increase in risk of major malformations and neurodevelopmental disorders. Given these risks, should it be a treatment option for women of childbearing age?
Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero
Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.